16th Annual Strategic Project & Portfolio Management for Pharma
As the strategic and operating environment for Pharmaceutical R&D becomes more cost-constrained and evolving portfolios require increasingly more investment, critical decision-making and methodology is evidently a crucial element in PPM.
The conference will look at how to structure portfolio management into the organization, how to transform R&D indicators and PPM parameters into successful revenue producing projects and portfolios that align corporate business goals. This year approach will be both on technical side, on understanding how right processes, realistic analysis and correct interpretation of data can be translated into market success; but also how organizational aspects, how capacity management, leadership skills can build high performing teams and strategic decision making.
Importantly, this conference will not neglect the other essential topics including prioritisation, internal resource management, risk management and especially de-risking strategies (partnerships, outsourcing) as main factor of market success, managing pipeline from early stage to commercial stage, with a view on market access and generic portfolio management.
– Gain practical methodology to implement efficiently portfolio management
– Maximise portfolio value under limited budgets
– Benefit from early stage decision making
– Link portfolio decisions to market development
– Balance internal investments with external resources and partnerships
Cardiology, Clinical Genetics, Clinical Immunology, Clinical Pharmacology, Diabetology, Endocrinology, Epidemiology, Internal Medicine, Public Health
from: 2017-02-10 to: 2017-02-12 Fee: Not specified
Dear Colleagues, The 3rd World Congress of Clinical Lipidology to be hosted in the beautiful city of Brisbane, Australia will build on the...